SAN CARLOS, Calif.--(BUSINESS WIRE)--Lipoprotein(a) Foundation: Lipoprotein(a), also known as Lp(a), is currently the strongest monogenetic risk factor for coronary heart disease and aortic stenosis.
Lipoprotein(a) or Lp(a) is a genetically controlled risk factor for a heart attack. Cardiologist explains why it's important to be aware of your levels.
New evidence shows regular aspirin use is associated with a lower incidence of aortic valve calcification and aortic stenosis ...
Elevated lipoprotein(a) levels can slowly block the arteries, increasing the likelihood of cardiovascular disease. Since no treatment is currently available for this condition, it is essential to ...
Muvalaplin, an oral, once-daily treatment that inhibits lipoprotein(a) formation via a novel mechanism, achieved positive results in a 12-week Phase 2 study These data were published in the Journal of ...
Review in The Lancet finds that one in five globally are at risk of contracting cardiovascular diseases, because they carry a genetic risk of high levels of a specific lipoprotein, which can be tested ...
For years, heart health conversations have focused on familiar numbers: LDL, HDL, and triglycerides. These markers appear in almost every routine cholesterol report. Yet cardiologists say an important ...
Lipoprotein(a) levels greater 30 mg/dL linked to increased 30-year risk for major CV events and coronary heart disease. (HealthDay News) — Among women, very high levels of lipoprotein(a) are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results